Company Filing History:
Years Active: 2021
Title: Innovations of Ana Sofia Teixeira Esteves in Neurodegenerative Disease Treatment
Introduction
Ana Sofia Teixeira Esteves is an accomplished inventor based in Vila Nova de Gaia, Portugal. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and patent applications. Her work focuses on the therapeutic use of specific compounds to address critical health challenges.
Latest Patents
Ana Sofia Teixeira Esteves holds a patent for the use of citalopram or escitalopram, along with their pharmaceutically acceptable salts or derivatives, in the treatment of neurodegenerative diseases. This patent emphasizes the importance of these compounds in reducing protein misfolding and aggregation, which are key factors in the progression of such diseases. The method of administration is particularly noted for its oral delivery, making it a practical option for patients.
Career Highlights
Ana is affiliated with the University of Minho, where she has been involved in groundbreaking research. Her academic background and dedication to her field have positioned her as a leading figure in the study of neurodegenerative conditions. Her innovative approach has garnered attention and respect within the scientific community.
Collaborations
Ana has collaborated with notable colleagues, including Patricia Espinheira De Sá Maciel and Andreia Cristiana Teixeira De Castro. These partnerships have enhanced her research efforts and contributed to the advancement of knowledge in her area of expertise.
Conclusion
Ana Sofia Teixeira Esteves exemplifies the spirit of innovation in the medical field, particularly in the treatment of neurodegenerative diseases. Her patent and collaborative efforts reflect her commitment to improving patient outcomes through scientific research.